ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,099.96
      1.02%
      US Tech 100
      17,244.80
      1.57%
      Dow Jones
      38,239.66
      0.40%
      Brent Oil
      88.165
      0.00%
      Bitcoin
      63,192.07
      -0.86%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Mainz BioMed NV (MYNZ)

      7. Mainz BioMed NV (MYNZ) News

      MYNZ Mainz BioMed NV

      0.83
      -0.0268 (-3.13%)
      Apr 26 2024 - Closed
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      Mainz BioMed NV MYNZ NASDAQ Common Stock
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      -0.0268 -3.13% 0.83 19:57:21
      Open Price Low Price High Price Close Price Prev Close
      0.8655 0.78 0.8794 0.8181 0.8568
      more quote information »

      Recent News

      Date Time Source Heading
      4/25/202409:29GLOBEMainz Biomed Reports Positive Topline Results from Pooled..
      4/09/202408:01GLOBEMainz Biomed Reports Full Year 2023 Financial Results
      3/19/202408:01GLOBEMainz Biomed Organizes HALLO DOC! Event to Highlight..
      3/18/202408:01GLOBEMainz Biomed: Webinar on Early Detection of Colorectal..
      3/12/202408:01GLOBEMainz Biomed Presents ColoAlert® at UDH Congress 2024:..
      3/05/202408:01GLOBEMainz Biomed Partners with Trusted Health Advisors to..
      2/27/202408:01GLOBEMainz Biomed to Showcase at the Gynecology Conference in..
      2/22/202408:01GLOBEMainz Biomed Announces Distribution Partnership with..
      2/21/202408:01GLOBEMainz Biomed Establishes Strategic Partnership with TomaLab..
      2/06/202408:01GLOBEMainz Biomed Establishes Physician-Led Laboratory Expanding..
      1/11/202408:01GLOBEMainz Biomed and TestDNA Drive CRC Innovation at the 10th..
      1/09/202408:01GLOBEMainz Biomed Provides Year-End Corporate Review 2023
      12/19/202308:01GLOBEMainz Biomed and Bantleon Partner to Elevate Corporate..
      12/12/202308:01GLOBEMainz Biomed Showcases ColoAlert® at Two Prominent..
      12/05/202309:01GLOBEMainz Biomed Reports Positive Topline Results from U.S...
      11/29/202308:01GLOBEMainz Biomed’s Presentation at the 35th Annual Piper Sandler..
      11/20/202308:01GLOBEMainz Biomed to Present at the 35th Annual Piper Sandler..
      11/16/202308:01GLOBEMainz Biomed Reports Third Quarter 2023 Financial Results..
      11/15/202309:01GLOBEMainz Biomed Announces Closing of $5.0 million Registered..
      11/13/202309:00GLOBEMainz Biomed Announces Pricing of $5.0 million Registered..
      11/09/202308:01GLOBEMainz Biomed Partners with Liquid Biosciences to Harness the..
      11/07/202308:01GLOBEMainz Biomed to Showcase ColoAlert® at Leading Global..
      10/31/202308:01GLOBEMainz Biomed Reports Success from Employee Colorectal Cancer..
      10/26/202308:01GLOBEMainz Biomed Appoints Tarrin Khairi-Taraki as VP of..
      10/18/202308:01GLOBEMainz Biomed Presents Groundbreaking Results of ColoFuture..
      10/11/202308:01GLOBEMainz Biomed to Showcase ColoAlert® at UEG Week 2023 in..
      10/05/202308:01GLOBEMainz Biomed to Attend the JonesTrading 2023 Healthcare..
      10/04/202308:01GLOBEMainz Biomed Announces Live Launch of ColoAlert® with..
      9/27/202308:01GLOBEMainz Biomed to Present Detailed Results of ColoFuture Study..
      9/20/202303:01GLOBEMainz Biomed to Present at the Cantor Fitzgerald Global..
      9/13/202303:01GLOBEMainz Biomed’s ColoFuture Study, Evaluating its Novel mRNA..
      9/05/202303:01GLOBEMainz Biomed Announces Strategic Partnership with Ärztliches..
      8/29/202303:01GLOBEMainz Biomed to Present at the H.C. Wainwright Global..
      8/22/202303:01GLOBEMainz Biomed Announces Live Launch of ColoAlert® with..
      8/15/202306:23EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      8/15/202303:01GLOBEMainz Biomed Announces Financial Half Year Results 2023 and..
      8/01/202303:01GLOBEMainz Biomed Announces Live Launch of ColoAlert® with..
      7/18/202303:01GLOBEMainz Biomed Announces Collaboration with Fugene Genetics in..
      7/11/202316:35EDGAR2Form S-8 - Securities to be offered to employees in employee..
      7/11/202316:15EDGAR2Form D - Notice of Exempt Offering of Securities
      6/29/202303:01GLOBEMainz Biomed Secures up to $50M in New Funding
      6/28/202316:31EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      6/28/202316:30EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
      6/28/202303:01GLOBEMainz Biomed to Attend ESMO World Congress on..
      6/20/202303:01GLOBEMainz Biomed Expands into Romania Through Partnership with..
      5/31/202303:01GLOBEMainz Biomed Expands Commercial Footprint into Poland
      5/24/202303:01GLOBEMainz Biomed Processes First Patients from Colorectal Cancer..
      5/16/202303:01GLOBEMainz Biomed Announces First Quarter 2023 Financial Results..
      5/10/202303:01GLOBEMainz Biomed Partners with Microba Life Sciences for the..
      5/03/202303:01GLOBEMainz Biomed Announces Addition of Eurofins GeLaMed to its..

      Your Recent History

      NASDAQ
      MYNZ
      Mainz BioMed NV
      Delayed Upgrade Clock